Welcome to LookChem.com Sign In|Join Free

CAS

  • or

54113-73-4

Post Buying Request

54113-73-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

54113-73-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 54113-73-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,1,1 and 3 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 54113-73:
(7*5)+(6*4)+(5*1)+(4*1)+(3*3)+(2*7)+(1*3)=94
94 % 10 = 4
So 54113-73-4 is a valid CAS Registry Number.

54113-73-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-chloro-2-((phenoxycarbonyl)amino)benzoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:54113-73-4 SDS

54113-73-4Relevant articles and documents

Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase-6 Inhibitors for Treatment of Non-Small Cell Lung Cancer

Yu, Chao-Wu,Hung, Pei-Yun,Yang, Hui-Ting,Ho, Yi-Hsun,Lai, Hsing-Yi,Cheng, Yi-Sheng,Chern, Ji-Wang

, p. 857 - 874 (2019/01/08)

We designed and synthesized quinazolin-2,4-dione-based hydroxamic acids to serve as selective competitive inhibitors of histone deacetylase-6 (HDAC6). The most potent and selective compound, 3d (IC50, 4 nM, HDAC6; IC50 > 10 μM, HDAC1

QUINAZOLINE DERIVATIVES AS ANTIVIRAL AGENTS

-

Page/Page column 28-29, (2010/11/26)

The present invention relates to the use of quinazoline derivatives of formula (I) wherein A, B, R1, R2, R3 and R4 are defined herein, and pharmaceutically acceptable salts thereof, for the treatment or preventi

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 54113-73-4